Inari Medical Acquires LimFlow S.A.

Liminatus Pharma Proposed Merger to Acquire InnocsAI for $320M in Stock

May 21, 2026

Healthcare Services

Liminatus Pharma has entered into a definitive merger agreement to acquire InnocsAI via a newly formed wholly owned Delaware subsidiary. The deal values InnocsAI at approximately $320 million, with InnocsAI’s members receiving 1.6 billion Liminatus shares at $0.20 per share plus contingent value rights (CVRs) tied to 20% of future net proceeds from certain strategic transactions involving the acquired assets.

VitalHub Acquires Novari Health

July 7, 2025

Healthcare Services

VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.

Stryker To Acquire Inari Medical for $4.9 Billion

January 7, 2025

Medical Devices

Stryker, a medical technologies company, announced a definitive agreement to acquire Inari Medical in an all-cash transaction valued at approximately $4.9 billion ($80 per share). Following the tender offer, the acquisition will be completed via a second-step merger at the same price, with closing anticipated by the end of Q1 2025.

Aileron Therapeutics Acquires Lung Therapeutics

October 31, 2023

Biotechnology

Aileron Therapeutics, Inc. (NASDAQ: ALRN) completed a stock-for-stock acquisition of Lung Therapeutics, Inc., bringing the clinical-stage pulmonary and fibrosis-focused pipeline (including lead candidate LTI-03) into Aileron's portfolio. Immediately after the acquisition Aileron arranged a private placement led by Bios Partners (with participation from Nantahala Capital and others) to raise approximately $18 million to fund ongoing development, including a Phase 1b trial of LTI-03.

LeMaitre Vascular Acquires Artegraft

June 22, 2020

Medical Devices

LeMaitre Vascular, Inc. acquired the business and assets of Artegraft, Inc. for $90.0 million (including $72.5 million at closing and up to $17.5 million in earnouts). The acquisition adds Artegraft's biologic vascular graft product line (used primarily for hemodialysis access) to LeMaitre's portfolio and will keep Artegraft's North Brunswick, New Jersey manufacturing facility and most employees in place.

LABORIE Medical Technologies Acquires Clinical Innovations for $525M

December 20, 2019

Medical Devices

LABORIE Medical Technologies, a Patricia Industries portfolio company, has completed the acquisition of Clinical Innovations from funds managed by EQT for an enterprise value of $525 million. Clinical Innovations, headquartered in Salt Lake City, Utah, is a leading provider of single-use medical devices for labor & delivery and neonatal intensive care and will form a stand-alone Maternal and Child Health global business unit within LABORIE.